Replies to post #17954 on Momenta Pharmaceuticals, Inc. (MNTA)

[alternatepatel]

Cancellation could be related to the pending P1 SAD MAD data.

I doubt it has anything to do with FDA inspection as MNTA will have no role in inspection.